Targeted over-expression of endothelin-1 in astrocytes leads to more severe brain damage and vasospasm after subarachnoid hemorrhage
Article Nov 05, 2013
P.K.K. Yeung, J. Shen, S.S.M. Chung, S.K. Chung
Background - Endothelin-1 (ET-1) is a potent vasoconstrictor, and astrocytic ET-1 is reported to play a role in the pathogenesis of cerebral ischemic injury and cytotoxic edema. However, it is still unknown whether astrocytic ET-1 also contributes to vasogenic edema and vasospasm during subarachnoid hemorrhage (SAH). In the present study, transgenic mice with astrocytic endothelin-1 over-expression (GET-1 mice) were used to investigate the pathophysiological role of ET-1 in SAH pathogenesis.
Results - The GET-1 mice experienced a higher mortality rate and significantly more severe neurological deficits, blood–brain barrier breakdown and vasogenic edema compared to the non-transgenic (Ntg) mice following SAH. Oral administration of vasopressin V1a receptor antagonist, SR 49059, significantly reduced the cerebral water content in the GET-1 mice. Furthermore, the GET-1 mice showed significantly more pronounced middle cerebral arterial (MCA) constriction after SAH. Immunocytochemical analysis showed that the calcium-activated potassium channels and the phospho-eNOS were significantly downregulated, whereas PKC-α expression was significantly upregulated in the MCA of the GET-1 mice when compared to Ntg mice after SAH. Administration of ABT-627 (ETA receptor antagonist) significantly down-regulated PKC-α expression in the MCA of the GET-1 mice following SAH.
Conclusions - The present study suggests that astrocytic ET-1 involves in SAH-induced cerebral injury, edema and vasospasm, through ETA receptor and PKC-mediated potassium channel dysfunction. Administration of ABT-627 (ETA receptor antagonist) and SR 49059 (vasopressin V1a receptor antagonist) resulted in amelioration of edema and vasospasm in mice following SAH. These data provide a strong rationale to investigate SR 49059 and ABT-627 as therapeutic drugs for the treatment of SAH patients.
Prominent Neuroscientist Prof. Tom Jessell Fired Following InvestigationArticle
Prof. Thomas Jessell, 66, who holds an endowed Chair as the Claire Tow Professor of Motor Neuron Disorders at the Zuckerman Insitute of the University of Columbia, has had his employment terminated.READ MORE
Correlation Vs Causation Alert! -Anxiety Linked to Waist SizeArticle
Despite the large percentage of postmenopausal women that report to suffer from anxiety in this study, it is important to remember that correlation does not necessarily mean causation in this case.READ MORE
Curing Blindness With Stem Cells – Here’s The Latest ScienceArticle
In 2010 scientists successfully guided stem cells into becoming retina cells in a laboratory. It is hoped that these cells could later be delivered into the diseased eye to replace or preserve damaged retina cells.READ MORE